Mirjam Zeisel
  • E-mail :[email]
  • Phone : +33472681970
  • Location : Lyon, France
Last update 2021-07-12 11:04:35.73

Mirjam Zeisel PhD, PharmD

Course and current status

Since 2017

Chargé de recherche, Centre de Recherche en Cancérologie (CRCL) Inserm U1052, Lyon, France


Previous positions

  • Chargé de recherche, Inserm U1110 (ex U748), Strasbourg, France (2009-2017)
  • “Poste Vert” Inserm, Inserm U748, Strasbourg, France (2007-2008)
  • Postoc, Department of Medicine II, University Hospital of Freiburg, Germany (2005-2007)
  • PhD, Inserm U392, France (2001-2004)


University degrees and diplomas

  • Habilitation à diriger des recherches (HDR), Université de Strasbourg
  • PhD Immunology and Pharmacology, Université Louis Pasteur,
  • Master (DEA) Pharmacologie and pharmacochemistry, Université Louis Pasteur
  • PharmD (Docteur en Pharmacie), Université Louis Pasteur
  • Maîtrise des Sciences Biologiques et Médicales (MSBM), Université Louis Pasteur

Scientific summary

Virus-host interactions and liver disease

HCV and HBV are a major causes of hepatitis worldwide. Chronic viral hepatitis C or B may progress to liver cirrhosis and hepatocellular carcinoma (HCC). Efficient antiviral treatment and viral cure reduce but do not eliminate the risk of HCC development. Our research focuses on the characterization of virus host-interactions and the pathogenesis of viral infection. We are particularly interested in deciphering virus-induced alteration of regulatory networks involved in liver disease and cancer.

Image d’exemple